stockNYSE: ABBV • Last 28 Days Updates
AbbVie Stock
AbbVie discovers and delivers innovative medicines in immunology (Humira, Skyrizi, Rinvoq), oncology, and neuroscience.
✓ Latest Close USD
$256.46
Latest session close
+$10.42vs period start
Period Return % % GAIN
+4.24%
Net period trajectory
Cumulative ReturnNormalized
High / Low Range SPREAD
$266.97 / $241.95
Period range envelope
$25.02channel spread
Total Volume SHARES
90.38M
Period turnover
Avg: 4.30M/dLiquidity
Price & Performance Trajectory
Interactive time series. Toggle metrics in scorecards above to customize chart views.
Historical Session Ledger
Daily open, high, low, and close prices with volume and period returns.
Historical Quotes & Breakdown(21 dates)
| Date | Close (USD) | Return % | High | Low | Volume |
|---|---|---|---|---|---|
| Aug 07, 2026 | $246.04 | +0.89% | $246.76 | $241.95 | 4.93M |
| Aug 10, 2026 | $247.97 | +0.78% | $248.01 | $244.03 | 4.21M |
| Aug 11, 2026 | $250.09 | +0.85% | $250.77 | $247.18 | 4.49M |
| Aug 12, 2026 | $248.76 | -0.53% | $250.09 | $245.52 | 3.78M |
| Aug 13, 2026 | $250.82 | +0.83% | $255.30 | $249.35 | 4.37M |
| Aug 14, 2026 | $249.46 | -0.54% | $250.61 | $247.68 | 4.20M |
| Aug 17, 2026 | $250.33 | +0.35% | $251.49 | $248.31 | 4.65M |
| Aug 18, 2026 | $258.92 | +3.43% | $259.18 | $252.41 | 5.01M |
| Aug 19, 2026 | $265.97 | +2.72% | $266.97 | $259.55 | 5.54M |
| Aug 20, 2026 | $261.83 | -1.56% | $265.93 | $260.48 | 5.23M |
| Aug 21, 2026 | $264.96 | +1.20% | $266.84 | $260.10 | 5.16M |
| Aug 24, 2026 | $264.52 | -0.17% | $266.04 | $262.07 | 3.88M |
| Aug 25, 2026 | $265.79 | +0.48% | $266.91 | $263.03 | 3.67M |
| Aug 26, 2026 | $262.90 | -1.09% | $265.00 | $260.31 | 3.31M |
| Aug 27, 2026 | $258.15 | -1.81% | $262.50 | $257.25 | 4.76M |
Page 1 of 2